Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

226 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-13

Study Completion Date

2022-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Depression and anxiety in female patients with cancer are serious comorbidities that affect the quality of life for patients and their survival rates as they have poorer health outcomes. This validation study is a part of the study on the prevalence of depression and anxiety among breast cancer patients. This study aims to investigate the validity of the Kazakh and Russian versions of the Beck Depression Inventory (BDI-II) and Beck Anxiety Inventory (BAI) among female cancer patients in Almaty, Kazakhstan.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of Depression and Anxiety Among Breast Cancer Patients

NCT05011409

Depression Anxiety Breast Cancer

COMPLETED

Reduction of Pre-operative Anxiety Using a Specially Designed Educational Program for Breast Cancer Patients Undergoing Surgery: a Randomized Controlled Trial

NCT05887856

Patient Satisfaction Preoperative Anxiety Anxiety

ENROLLING_BY_INVITATION NA

Online Psychological Care Program for Women Who Attend a Breast Clinic.

NCT05830461

Breast Cancer

UNKNOWN NA

Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty

NCT01553097

Breast Cancer Neurocognitive Impairment Quality of Life

COMPLETED

Brief CBT for Anxiety and Advanced Cancer

NCT00706290

Anxiety Depression Unspecified Adult Solid Tumor, Protocol Specific +2 more

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Anxiety Breast Cancer Ovarian Cancer Cervical Cancer Lung Cancer Colon Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Female Cancer Patients

Female cancer patients with no history of previously diagnosed depression or anxiety and who have been referred to or have been receiving treatment at Almaty Oncology Center or Kazakh Scientific Research Institute of Oncology and Radiology

Beck Depression Inventory-21 (diagnostic survey)

Intervention Type OTHER

Kazakh or Russian versions of the Beck Depression Inventory-21will be filled by female cancer patients

Beck Anxiety Inventory

Intervention Type OTHER

Kazakh or Russian versions of the Beck Anxiety Inventory will be filled by female cancer patients

Interview using The International Classification of Diseases in tenth edition (ICD-10) criteria

Intervention Type OTHER

Interview using The International Classification of Diseases in tenth edition (ICD-10) criteria as a gold standard of diagnosing depression or anxiety

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Beck Depression Inventory-21 (diagnostic survey)

Kazakh or Russian versions of the Beck Depression Inventory-21will be filled by female cancer patients

Intervention Type OTHER

Beck Anxiety Inventory

Kazakh or Russian versions of the Beck Anxiety Inventory will be filled by female cancer patients

Intervention Type OTHER

Interview using The International Classification of Diseases in tenth edition (ICD-10) criteria

Interview using The International Classification of Diseases in tenth edition (ICD-10) criteria as a gold standard of diagnosing depression or anxiety

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BDI-II BAI

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult female patients between 18 and 65 years of age with a primary diagnosis of breast cancer; ovarian cancer; cervical cancer; colon cancer; lung cancer;
* Russian or Kazakh language fluency;
* consent to participate;